Blue Water Life Science Advisors, LP 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Blue Water Life Science Advisors, LP disclosed 8 US equity positions worth $126.3m in its Q2 2025 13F filing. The largest position was NTRA at 22.3% of the reported book, followed by ADPT and GH. Against the Q1 2025 filing, it opened 1 new position, added to 2 and reduced 2 among the top 8 holdings.
What did Blue Water Life Science Advisors, LP own in Q2 2025? Top 8 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | NTRA NATERA INC | Healthcare | 22.3% | $28.1m | 166,494 | -20% | reduced |
| 2 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 19.8% | $25.0m | 2,145,145 | 0% | held |
| 3 | GH GUARDANT HEALTH INC | Healthcare | 18.1% | $22.8m | 439,047 | -37% | reduced |
| 4 | CDNA CAREDX INC | Healthcare | 11.2% | $14.1m | 724,014 | 0% | held |
| 5 | TXG 10X GENOMICS INC-CLASS A | Healthcare | 10.1% | $12.7m | 1,100,720 | – | new |
| 6 | PSNL PERSONALIS INC | Healthcare | 8.7% | $11.0m | 1,676,300 | 43% | added |
| 7 | QTRX QUANTERIX CORP | Healthcare | 5.0% | $6.4m | 957,747 | 157% | added |
| 8 | AKOYA BIOSCIENCES INC | 4.8% | $6.1m | 4,697,785 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.